Chronic daily headache

Current Opinion in Neurology

Volumn 13, Issue 3, 2000, Pages 277-283

  Silberstein, Stephen D ^a   Lipton, Richard B ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ERGOT DERIVATIVE;

CHRONIC DISEASE; COMORBIDITY; DISEASE CLASSIFICATION; DRUG ABUSE; HEADACHE; HUMAN; MIGRAINE; PATHOPHYSIOLOGY; PSYCHIATRY; REVIEW;

CHRONIC DISEASE; HEADACHE; HUMANS; PROGNOSIS; TIME FACTORS;

EID: 0034085631     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200006000-00008     Document Type: Review

References (37)

1. 1 Scher Al, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 1998; 38:497-506. The first population-based study of the prevalence of different CDH types.
2. 2 Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999; 39:190-196. A large population study with in-person clinical assessments.
3. 3 Wang SJ, Fuh JL, Lu SR, Liu CY, Hsu LC, Wang PN, Liu HC. Chronic daily headache in Chinese elderly: prevalence, risk factors and biannual follow-up. Neurology 2000; 54:314-319. An analysis of the prevalence and predictive factors for the management of CDH.
4. 4 Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 1994; 34:1-7.
5. 5 Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996; 47:871-875.
6. 6 Guitera V, Munoz P, Castillo J, Pascual J. Transformed migraine: a proposal for the modification of its diagnostic criteria based on recent epidemiological data. Cephalalgia 1999; 19:847-850.
7. 7 Monzón MJ, Láinez MJ, Morales F, Sancho J. Clinical characteristics of chronic daily headache [Abstract]. Cephalalgia 1999; 19:410.
8. 8 Mathew NT. Transformed or evolutional migraine. Headache 1987; 27:305-306.
9. 9 Russell MB, Stergaard S, Endtsen L, Olesen J. Familial occurrence of chronic tension-type headache. Cephalalgia 1999; 19:207-210. This study provides evidence that CTTH aggregates within families.
10. 10 Newman LC, Lipton RB, Solomon S. Hemicrania continua: 7 new cases and a literature review. Headache 1993; 32:267.
11. 11 Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomie features, including new cases. Brain 1997; 120 (Part 1):193-209.
12. 12 Espada F, Morales-Asin F, Escalza I, Navas I, Iñiguez C, Mauri JA. Hemicrania continua: nine new cases [Abstract]. Cephalalgia 1999; 19:442.
13. 13 Katsarava Z, Limmroth V, Fritsche G, Diener HC. Drug-induced headache following the use of zolmitriptan or naratriptan [Abstract]. Cephalalgia 1999; 19:414.
14. 14 Mitsikostas DD, Thomas AM. Comorbidity of headache and depressive disorders. Cephalalgia 1999; 19:211-217.
15. 15 Verri AP, Cecchini P, Galli C, Granella F, Sandrini G, Nappi G. Psychiatric comorbidity in chronic daily headache. Cephalalgia 1998; 18:45-49.
16. 16 Curioso EP, Young WB, Shechter AL, Kaiser RS. Psychiatric comorbidity predicts outcome in chronic daily headache patients [Abstract]. Neurology 1999; 52:A471.
17. 17 Monzon MJ, Lainez MJ. Quality of life in migraine and chronic daily headache patients. Cephalalgia 1998; 18:638-643.
18. 18 Mitsikostas DD, Thomas A, Gatzonis S, Ilias A, Papageorgia G. An epidemiologic study of headache among the monks of Athos (Greece). Headache 1994; 34:539-541.
19. 19 Tekle Haimanot R, Seraw B, Forsgren L, Ekbom K, Ekstedt J. Migraine, chronic tension-type headache, and cluster headache in an Ethiopian rural community. Cephalalgia 1995; 15:482-488.
20. 20 Rasmussen BK. Epidemiology of headache. Cephalalgia 1995; 15:45-68.
21. 21 Yamamura H, Malick A, Chamberlin NL, Burstein R. Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine. J Neurophysiol 1999; 81:479-493.
22. 22 Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brainstem trigeminal neurons. J Neurophysiol 1998; 79:964-982. An elegant study on central sensitization.
23. 23 Fusco BM, Colantoni O, Giavovazzo M. Alteration of central excitation circuits in chronic headache and analgesic misuse. Headache 1997; 37:486-491.
24. 24 Fusco BM, Colantoni O, Saturnino C, Geppetti P, Bianchi A. Altered second pain in chronic headaches: pharmacological modulation [Abstract]. Cephalalgia 1999; 19:399-400.
25. 25 Sakai F, Ebihara S, Akiyama M, Horikawa M. Pericranial muscle hardness in tension-type headache: a noninvasive measurement method and its clinical application. Brain 1995; 118:523-531.
26. 26 Ashina M, Bendtsen L, Jensen R, Sakai F, Olesen J. Muscle hardness in patients with chronic tension-type headache: relation to actual headache state. Pain 1999; 79:201-205.
27. 27 Cerbo R, Barbanti P, Fabbrini G, Pascali MP, Catarci T. Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications. Headache 1998; 38:453-457.
28. 28 Edwards K, Santarcangelo V, Shea P, Edwards J. Intravenous valproate for acute treatment of migraine headaches [Abstract]. Cephalalgia 1999; 19:356.
29. 29 Shuaib A, Ahmed F, Muratoglu M, Kochanski P. Topiramate in migraine prophylaxis: a pilot study [Abstract]. Cephalalgia 1999; 19:379-380.
30. 30 Fontes-Ribeiro CA. 1-5-hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind randomized placebo-controlled study [Abstract]. Cephalalgia 1999; 19:453.
31. 31 Porta M, Loiero M, Gamba M. Treatment of tension-type headache by botulinum toxin in pericranial muscles [Abstract]. Cephalalgia 1999; 19:453-454.
32. 32 Smuts JA, Baker MK, Smuts HM, Tassen JM, Ossouw E, Barnard PW. Botulinum toxin type A as prophylactic treatment in chronic tension-type headache [Abstract]. Cephalalgia 1999; 19:454.
33. 33 Gobel H, Lindner V, Krack P, Heinze A, Gaartz N, Deuschl G. Treatment of chronic tension-type headache with botulinum toxin [Abstract]. Cephalalgia 1999; 19:455.
34. 34 Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomized crossover trial. Lancet 1999; 353:287-289.
35. 35 Pringsheim T, Howse D. Inpatient treatment of chronic daily headache using dihydroergotamine: a long-term followup study. Can J Neurol Sci 1998; 25:146-150.
36. 36 Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 1999; 19:44-49.
37. 37 Monzon MJ, Lainez MJA, Morales F, Sancho J. Long-term prognosis of chronic daily headache [Abstract]. Cephalalgia 1999; 19:410.